About Octune Pharma Solutions Private Limited
Data last updated:
Octune Pharma Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2015PTC099128. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vayalpate Dayamayi and Vayalpati Venkat Chaitanya.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Plot No. 45 Municipal No. 1 – 98/9/45 Jai Hind Enclave Madhapur S2, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2018, the company reported a revenue of ₹1.37 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹6.63 Lakh (net margin 4.8%) and EBITDA of ₹15.95 Lakh (EBITDA margin 11.7%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website octunepharma.com.
Company details
Contact details
Octune Pharma Solutions Private Limited's registered office is in Hyderabad, Telangana. Its website is octunepharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressPlot No. 45 Municipal No. 1 – 98/9/45 Jai Hind Enclave Madhapur S2, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Octune Pharma Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Octune Pharma Solutions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Octune Pharma Solutions Private Limited, buy the company report.
Financials of Octune Pharma Solutions Private Limited
FY 2018 filings availableOctune Pharma Solutions Private Limited reported revenue of ₹1.37 Cr (up 14% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year. EBITDA rose 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.37 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹15.95 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹6.63 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 11.7% | ||
| Net Profit Margin | 4.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Octune Pharma Solutions Private Limited, buy the company report.
Board of directors of Octune Pharma Solutions Private Limited
Octune Pharma Solutions has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vayalpate Dayamayi | Director | 31 Aug 2017 | 9 Years 1 Months | Current |
| Vayalpati Venkat Chaitanya | Director | 29 May 2015 | 11 Years 4 Months | Current |
Peer comparison
Octune Pharma Solutions Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Octune Pharma Solutions Private Limitedthis company | ₹1.37 Cr (FY 2018) | ₹6.63 Lakh | 4.8% | 14.0% | Hyderabad, Telangana, India | |
| HCR Formulations Private Limited | ₹1.37 Cr (FY 2025) | -34.0% | Ahmedabad, Gujarat, India | |||
| Torcium Biotech Private Limited | ₹1.36 Cr (FY 2025) | 6.0% | Jaipur, Rajasthan, India | |||
| Shree Vinayaka Life Sciences Private Limited | ₹1.36 Cr (FY 2025) | -65.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Octune Pharma Solutions Private Limited, buy the company report.
Auditor
Octune Pharma Solutions Private Limited is audited by V A S G & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V A S G & ASSOCIATES | FY 2018 | 006070S |
Shareholding
The shareholding of Octune Pharma Solutions Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Octune Pharma Solutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Octune Pharma Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Octune Pharma Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Octune Pharma Solutions has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Octune Pharma Solutions Private Limited, buy the company report.
Recent activity
Octune Pharma Solutions Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Vishal Singh Thakur ceased to be Director on 21 Sep 2017.
Frequently asked questions
Octune Pharma Solutions is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 2015 (11+ years old) and is registered under CIN U51909TG2015PTC099128.
Octune Pharma Solutions has 2 current directors:
- Vayalpate Dayamayi - Director
- Vayalpati Venkat Chaitanya - Director
The latest financial statements of Octune Pharma Solutions on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2016 are in the company report.
No. Octune Pharma Solutions has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Octune Pharma Solutions is U51909TG2015PTC099128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Octune Pharma Solutions was incorporated on 29 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Octune Pharma Solutions by revenue are HCR Formulations Private Limited, Torcium Biotech Private Limited, Shree Vinayaka Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vishal Singh Thakur ceased to be Director on 21 Sep 2017. Vayalpate Dayamayi was appointed as Director on 31 Aug 2017. Arundathi Reddy Gaddam ceased to be Director on 05 Nov 2016. Octune Pharma Solutions has 4 board changes on record in total.
Octune Pharma Solutions can be reached through the website octunepharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Octune Pharma Solutions is at Plot No. 45 Municipal No. 1 – 98945 Jai Hind Enclave Madhapur S2, Hyderabad, Telangana, India – 500081.
Octune Pharma Solutions operates in the pharma industry, in the drug formulation and development segment.